EarningsNxt
CalendarInsightsFor AgentsAbout
EarningsNxt

Earnings briefings in plain English, before and after the bell. Free calendar, Pro briefs at $8/mo.

Get briefs in your inbox For agents

Popular tickers

AAPLMSFTGOOGLAMZNNVDAMETATSLAJPMVUNHJNJWMT

Product

  • Earnings Calendar
  • Pricing
  • For Agents

Resources

  • Insights
  • API Reference
  • FAQ
  • llms.txt

Company

  • About
  • Contact
  • X / Twitter
  • StockTwits
  • Instagram

© 2026 EarningsNxt. For informational purposes only. Not financial advice. AI-assisted content may contain errors.

Terms of ServicePrivacy PolicyDisclaimerDisclosureAccessibilityDo Not Sell My Info
  1. Home
  2. HALO

Equity Profile

HALO

Halozyme Therapeutics, Inc.

Health CareBiotechnology$12.5B market cap

Earnings scorecard

Last 76Q

EPS beat streak

2Q

EPS beat rate

59%

Avg EPS surprise

+4.74%

Avg 1-day reaction

+0.54%

Earnings history

77 quarters
Full history
QuarterReportedEst.ActualSurprise1-day
Q3-2026UpcomingNov 2, 2026————Preview
Q2-2026Aug 6, 2026$1.82$2.28+32.17%+2.60%Preview
Q1-2026May 11, 2026$1.52$1.60+9.74%+3.57%Preview
Q4-2025Feb 17, 2026$2.06$-0.24-111.62%+1.31%Preview
Q3-2025Nov 3, 2025$1.54$1.72+11.40%+1.55%Preview
Q2-2025Aug 5, 2025ProPreview
Q1-2025May 6, 2025ProPreview
Q4-2024Feb 18, 2025ProPreview
Q3-2024Oct 31, 2024ProPreview
Q2-2024Aug 6, 2024ProPreview
Q1-2024May 7, 2024ProPreview
Q4-2023Feb 20, 2024ProPreview
Q3-2023Nov 6, 2023ProPreview
Q2-2023Aug 8, 2023ProPreview
Q1-2023May 9, 2023ProPreview
Q4-2022Feb 21, 2023ProPreview
Q3-2022Nov 8, 2022ProPreview
Q2-2022Aug 9, 2022ProPreview
Q1-2022May 10, 2022ProPreview
Q4-2021Feb 22, 2022ProPreview
Q3-2021Nov 2, 2021ProPreview
Q2-2021Aug 9, 2021ProPreview
Q1-2021May 10, 2021ProPreview
Q4-2020Feb 23, 2021ProPreview
Q3-2020Nov 2, 2020ProPreview
Q2-2020Aug 10, 2020ProPreview
Q1-2020May 11, 2020ProPreview
Q4-2019Feb 24, 2020ProPreview
Q3-2019Nov 12, 2019ProPreview
Q2-2019Aug 6, 2019ProPreview
Q1-2019May 7, 2019ProPreview
Q4-2018Feb 21, 2019ProPreview
Q3-2018Nov 6, 2018ProPreview
Q2-2018Aug 7, 2018ProPreview
Q1-2018May 10, 2018ProPreview
Q4-2017Feb 20, 2018ProPreview
Q3-2017Nov 7, 2017ProPreview
Q2-2017Aug 8, 2017ProPreview
Q1-2017May 9, 2017ProPreview
Q4-2016Feb 28, 2017ProPreview
Q3-2016Nov 7, 2016ProPreview
Q2-2016Aug 9, 2016ProPreview
Q1-2016May 9, 2016ProPreview
Q4-2015Feb 29, 2016ProPreview
Q3-2015Nov 9, 2015ProPreview
Q2-2015Aug 10, 2015ProPreview
Q1-2015May 11, 2015ProPreview
Q4-2014Mar 2, 2015ProPreview
Q3-2014Nov 10, 2014ProPreview
Q2-2014Aug 11, 2014ProPreview
Q1-2014May 12, 2014ProPreview
Q4-2013Feb 27, 2014ProPreview
Q3-2013Nov 8, 2013ProPreview
Q2-2013Aug 7, 2013ProPreview
Q1-2013May 8, 2013ProPreview
Q4-2012Feb 25, 2013ProPreview
Q3-2012Nov 8, 2012ProPreview
Q2-2012Aug 6, 2012ProPreview
Q1-2012May 7, 2012ProPreview
Q4-2011Mar 9, 2012ProPreview
Q3-2011Nov 7, 2011ProPreview
Q2-2011Aug 5, 2011ProPreview
Q1-2011May 6, 2011ProPreview
Q4-2010Mar 11, 2011ProPreview
Q3-2010Nov 5, 2010ProPreview
Q2-2010Aug 6, 2010ProPreview
Q1-2010May 7, 2010ProPreview
Q4-2009Mar 12, 2010ProPreview
Q3-2009Nov 6, 2009ProPreview
Q2-2009Aug 7, 2009ProPreview
Q1-2009May 8, 2009ProPreview
Q4-2008Mar 13, 2009ProPreview
Q3-2008Nov 6, 2008ProPreview
Q2-2008Aug 8, 2008ProPreview
Q1-2008May 8, 2008ProPreview
Q4-2007Mar 13, 2008ProPreview
Q3-2007Nov 8, 2007ProPreview

Next report

Q3-2026

Mon, Nov 2

After the close

Est. EPS

—

Est. Rev

—

Read the preview

About HALO

Sector
Health Care
Industry
Biotechnology
Market cap
$12.5B

72 earlier quarters of EPS results and stock reactions are part of Pro.

No charge today · $8/mo after 7 days · Cancel anytime

Q2-2025Aug 5, 2025ProPreview
Q1-2025May 6, 2025ProPreview
Q4-2024Feb 18, 2025Pro
Preview
Q3-2024Oct 31, 2024ProPreview
Q2-2024Aug 6, 2024ProPreview
Q1-2024May 7, 2024ProPreview
Q4-2023Feb 20, 2024ProPreview
Q3-2023Nov 6, 2023ProPreview
Q2-2023Aug 8, 2023ProPreview
Q1-2023May 9, 2023ProPreview
Q4-2022Feb 21, 2023ProPreview
Q3-2022Nov 8, 2022ProPreview
Q2-2022Aug 9, 2022ProPreview
Q1-2022May 10, 2022ProPreview
Q4-2021Feb 22, 2022ProPreview
Q3-2021Nov 2, 2021ProPreview
Q2-2021Aug 9, 2021ProPreview
Q1-2021May 10, 2021ProPreview
Q4-2020Feb 23, 2021ProPreview
Q3-2020Nov 2, 2020ProPreview
Q2-2020Aug 10, 2020ProPreview
Q1-2020May 11, 2020ProPreview
Q4-2019Feb 24, 2020ProPreview
Q3-2019Nov 12, 2019ProPreview
Q2-2019Aug 6, 2019ProPreview
Q1-2019May 7, 2019ProPreview
Q4-2018Feb 21, 2019ProPreview
Q3-2018Nov 6, 2018ProPreview
Q2-2018Aug 7, 2018ProPreview
Q1-2018May 10, 2018ProPreview
Q4-2017Feb 20, 2018ProPreview
Q3-2017Nov 7, 2017ProPreview
Q2-2017Aug 8, 2017ProPreview
Q1-2017May 9, 2017ProPreview
Q4-2016Feb 28, 2017ProPreview
Q3-2016Nov 7, 2016ProPreview
Q2-2016Aug 9, 2016ProPreview
Q1-2016May 9, 2016ProPreview
Q4-2015Feb 29, 2016ProPreview
Q3-2015Nov 9, 2015ProPreview
Q2-2015Aug 10, 2015ProPreview
Q1-2015May 11, 2015ProPreview
Q4-2014Mar 2, 2015ProPreview
Q3-2014Nov 10, 2014ProPreview
Q2-2014Aug 11, 2014ProPreview
Q1-2014May 12, 2014ProPreview
Q4-2013Feb 27, 2014ProPreview
Q3-2013Nov 8, 2013ProPreview
Q2-2013Aug 7, 2013ProPreview
Q1-2013May 8, 2013ProPreview
Q4-2012Feb 25, 2013ProPreview
Q3-2012Nov 8, 2012ProPreview
Q2-2012Aug 6, 2012ProPreview
Q1-2012May 7, 2012ProPreview
Q4-2011Mar 9, 2012ProPreview
Q3-2011Nov 7, 2011ProPreview
Q2-2011Aug 5, 2011ProPreview
Q1-2011May 6, 2011ProPreview
Q4-2010Mar 11, 2011ProPreview
Q3-2010Nov 5, 2010ProPreview
Q2-2010Aug 6, 2010ProPreview
Q1-2010May 7, 2010ProPreview
Q4-2009Mar 12, 2010ProPreview
Q3-2009Nov 6, 2009ProPreview
Q2-2009Aug 7, 2009ProPreview
Q1-2009May 8, 2009ProPreview
Q4-2008Mar 13, 2009ProPreview
Q3-2008Nov 6, 2008ProPreview
Q2-2008Aug 8, 2008ProPreview
Q1-2008May 8, 2008ProPreview
Q4-2007Mar 13, 2008ProPreview
Q3-2007Nov 8, 2007ProPreview